MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 9.34.
Share Price | ₹2,568.0 | Nov 19,2024 |
Market Cap | ₹102,899.8 Cr | |
Sales-TTM | ₹11,018.0 Cr | TTM-Consolidated Results |
Price/Sales | 9.34x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹102,899.8 Cr] as on Nov 19,2024
(/) Sales [ ₹11,018.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.34x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '9.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.78x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.9x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
MANKIND PHARMA | 11,018.0 | 9.34 | 102,899.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.47 | 425,930.0 |
CIPLA LTD | 26,512.0 | 4.48 | 118,828.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.37 | 101,290.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.44 | 95,280.3 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.17 | 156,524.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.33 | 104,742.0 |
LUPIN LTD | 21,431.3 | 4.34 | 92,929.7 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.39 | 72,478.2 |
ABBOTT INDIA LTD | 6,066.1 | 9.53 | 57,784.9 |
ALKEM LABORATORIES LTD | 12,706.2 | 5.20 | 66,062.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.39x |
Max industry PS | 18.17x |
Median industry PS | 5.20x |
Average industry PS | 7.19x |
You may also like the below Video Courses